510(k) K201089

ARK Lacosamide Assay by Ark Diagnostics, Inc. — Product Code NWM

K201089 is an FDA 510(k) premarket notification submitted by Ark Diagnostics, Inc. for the device "ARK Lacosamide Assay". The FDA issued a decision of Substantially Equivalent on Aug 5, 2021. The device falls under product code NWM (Immunoassay, Anti-Seizure Drug), a Class II device regulated under 21 CFR 862.3350. Ark Diagnostics, Inc. has 16 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Aug 5, 2021
Date Received
Apr 23, 2020
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Immunoassay, Anti-Seizure Drug
Device Class
Class II
Regulation Number
862.3350
Review Panel
TX
Submission Type
510(k)

To aid in management of patients treated with anti-seizure drug.

Need the full FDA record for Ark Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K201089. Report a data issue: hello@regdatalab.com.